GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Integrated Biopharma Inc (OTCPK:INBP) » Definitions » Days Inventory

Integrated Biopharma (Integrated Biopharma) Days Inventory : 89.41 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Integrated Biopharma Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Integrated Biopharma's Average Total Inventories for the three months ended in Mar. 2024 was $11.66 Mil. Integrated Biopharma's Cost of Goods Sold for the three months ended in Mar. 2024 was $11.90 Mil. Hence, Integrated Biopharma's Days Inventory for the three months ended in Mar. 2024 was 89.41.

The historical rank and industry rank for Integrated Biopharma's Days Inventory or its related term are showing as below:

INBP' s Days Inventory Range Over the Past 10 Years
Min: 63.28   Med: 73.04   Max: 83.95
Current: 83.95

During the past 13 years, Integrated Biopharma's highest Days Inventory was 83.95. The lowest was 63.28. And the median was 73.04.

INBP's Days Inventory is ranked worse than
51.09% of 1785 companies
in the Consumer Packaged Goods industry
Industry Median: 82.1 vs INBP: 83.95

Integrated Biopharma's Days Inventory increased from Mar. 2023 (76.23) to Mar. 2024 (89.41). It might indicate that Integrated Biopharma's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Integrated Biopharma's Inventory Turnover for the three months ended in Mar. 2024 was 1.02.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Integrated Biopharma's Inventory-to-Revenue for the three months ended in Mar. 2024 was 0.89.


Integrated Biopharma Days Inventory Historical Data

The historical data trend for Integrated Biopharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Biopharma Days Inventory Chart

Integrated Biopharma Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.07 74.99 73.55 83.55 83.46

Integrated Biopharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.23 76.74 78.43 94.08 89.41

Competitive Comparison of Integrated Biopharma's Days Inventory

For the Packaged Foods subindustry, Integrated Biopharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Biopharma's Days Inventory Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Integrated Biopharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where Integrated Biopharma's Days Inventory falls into.



Integrated Biopharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Integrated Biopharma's Days Inventory for the fiscal year that ended in Jun. 2023 is calculated as

Days Inventory (A: Jun. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Jun. 2022 ) + Total Inventories (A: Jun. 2023 )) / count ) / Cost of Goods Sold (A: Jun. 2023 )*Days in Period
=( (11.055 + 10.261) / 2 ) / 46.611*365
=10.658 / 46.611*365
=83.46

Integrated Biopharma's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

Days Inventory (Q: Mar. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (12.149 + 11.169) / 2 ) / 11.899*365 / 4
=11.659 / 11.899*365 / 4
=89.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrated Biopharma  (OTCPK:INBP) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Integrated Biopharma's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Integrated Biopharma's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Integrated Biopharma Days Inventory Related Terms

Thank you for viewing the detailed overview of Integrated Biopharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Biopharma (Integrated Biopharma) Business Description

Traded in Other Exchanges
N/A
Address
225 Long Avenue, Building 15, Hillside, NJ, USA, 07205
Integrated Biopharma Inc is a pharmaceutical company engaged in manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. It operates in two segments; Contract Manufacturing and Other Nutraceutical Businesses. It serves the needs of the nutraceutical industry by directly doing business as Chem International Inc. and through its operating subsidiaries; Manhattan Drug Company, Inc., AgroLabs, Inc., IHT Health Products, Inc. and MDC Warehousing and Distribution, Inc. The company generates maximum revenue from the Contract Manufacturing segment. The business operates and generates the majority of revenue from the United States.
Executives
Damon Desantis director 2424 N FEDERAL HIGHWAY, SUITE 208, BOCA RATON FL 33431
William H. Milmoe director, 10 percent owner 3299 N.W. 2ND AVENUE, BOCA RATON FL 33431
Joseph Laplaca director 72 EUGENE DRIVE, MONTVILLE NJ 07045
E Gerald Kay director, 10 percent owner, officer: Chairman and CEO C/O 225 LONG AVENUE, HILLSIDE NJ 07205
Bradley J Hoecker director STONINGTON PARTNERS, INC., 540 MADISON AVENUE, 25TH FLOOR, NEW YORK NY 10022
Jeffrey R Leach director, officer: President and CEO
Glenn Chang director C/O IBIO, INC., 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711
Vidadi Yusibov director C/O IBIOPHARMA, INC., 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711
Cd Financial, Llc 10 percent owner 3299 N.W. 2ND AVENUE, BOCA RATON FL 33431
Kay Riva director, officer: Vice President C/O 225 LONG AVENUE, HILLSIDE NJ 07205
Christina Kay director, officer: Vive President C/O 225 LONG AVENUE, HILLSIDE NJ 07205
Robert Canarick director C/O INTEGRATED BIOPHARMA, INC., 201 ROUTE 22, HILLSIDE NJ 07205
Robert Kay director C/O IBIO, INC., 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711
Dina Masi officer: Chief Financial Officer 14 LEXINGTON WAY, LONG VALLEY NJ 07853
Carl Desantis director, 10 percent owner C/O CDS INTERNATIONAL HOLDINGS, 3299 NW SECOND AVE, BOCA RATON FL 33431